(1)
Advancing BTK Inhibition: Non‑Covalent Bruton Tyrosine Kinase Inhibitors and Their Emerging Role in Canadian Practice. Can Hematol Today 2025, 4 (s04), 2–15. https://doi.org/10.58931/cht.2025.4s0469.